MX9709978A - Terapia de combinacion de antagonista de aldosterona epoxi-esteroidal y antagonista de angiotensina ii para tratamiento de insuficiencia cardiaca congestiva. - Google Patents

Terapia de combinacion de antagonista de aldosterona epoxi-esteroidal y antagonista de angiotensina ii para tratamiento de insuficiencia cardiaca congestiva.

Info

Publication number
MX9709978A
MX9709978A MX9709978A MX9709978A MX9709978A MX 9709978 A MX9709978 A MX 9709978A MX 9709978 A MX9709978 A MX 9709978A MX 9709978 A MX9709978 A MX 9709978A MX 9709978 A MX9709978 A MX 9709978A
Authority
MX
Mexico
Prior art keywords
angiotensin
epoxy
combination therapy
antagonist
receptor antagonist
Prior art date
Application number
MX9709978A
Other languages
English (en)
Inventor
John C Alenxander
Joseph R Schuh
Richard J Gorczynski
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of MX9709978A publication Critical patent/MX9709978A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una terapia de combinacion que comprende una cantidad terapéuticamente efectiva de un antagonista de receptor de aldosterona epoxi-esteroidal y una cantidad terapéuticamente efectiva de antagonista de receptor de angiotensina II para el tratamiento de trastornos circulatorios, incluyendo enfermedades cardiovasculares tales como hipertension, insuficiencia cardiaca congestiva, cirrosis y ascitis, los antagonistas de receptor de angiotensina II son aquellos compuestos que tiene potencia y biodisponibilidad elevadas y que se caracterizan porque tienen una porcion imidazol o triazol unida a una porcion bifenilmetilo o piridinilo/fenilmetilo; los antagonistas de receptor de aldosterona epoxi-esteroidal son compuestos de espiroxano esteroidales caracterizados por la presencia de una porcion epoxi 9a-,11a-substituida; una terapia de combinacion preferida incluye el antagonista de receptor de angiotensina II 5-[2-[5-[(3,5-dibutil-1H-1,2,4-triazol-1-il)metil] -2-piridinil]fenil-1H-tetrazol y el antagonista de receptor de aldosterona epoximexrenona.
MX9709978A 1995-06-07 1997-12-08 Terapia de combinacion de antagonista de aldosterona epoxi-esteroidal y antagonista de angiotensina ii para tratamiento de insuficiencia cardiaca congestiva. MX9709978A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60933595A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
MX9709978A true MX9709978A (es) 1998-03-31

Family

ID=39427973

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9709978A MX9709978A (es) 1995-06-07 1997-12-08 Terapia de combinacion de antagonista de aldosterona epoxi-esteroidal y antagonista de angiotensina ii para tratamiento de insuficiencia cardiaca congestiva.

Country Status (1)

Country Link
MX (1) MX9709978A (es)

Similar Documents

Publication Publication Date Title
IL122246A0 (en) Spironolactone and angiotensin II combination
WO1996040255A3 (en) Method to treat cardiofibrosis with a combination therapy of an angiotensin ii antagonist and an epoxy-steroidal aldosterone antagonist
WO2002009760A3 (en) Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
NZ310730A (en) Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for treatment of congestive heart failure
WO2004082599A3 (en) Combination of an aldosterone receptor antagonist and an anti-diabetic agent
AU7804501A (en) Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
DE69007740D1 (de) Substituierte 5-[(Tetrazolyl)alkenyl]-Imidazole.
IE902139L (en) Imidazolyl alkenoic acids
TW200507857A (en) Combination of an aldosterone receptor antagonist and an anti-obesity agent
NZ330889A (en) Cycloalkyl substituted imidazoles and their use in treating CSB/RK/p38 kinase mediated diseases
MY110205A (en) Imidazolyl-alkenoic acids.
HU9902075D0 (en) Angiotensin ii receptor blocking imidazole derivatives and pharmaceutical compositions containing them as active ingredients
EP0437103A3 (en) Substituted 5-(alkyl)carboxamide imidazoles
CA2085584A1 (en) Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists
IE62867B1 (en) 1h-substituted 1, 2, 4-triazole compounds for treatment of cardiovascular disorders
WO1992004335A3 (en) Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension
AU6564990A (en) Substituted n-(imidazolyl)alkyl alanine derivatives
MX9709978A (es) Terapia de combinacion de antagonista de aldosterona epoxi-esteroidal y antagonista de angiotensina ii para tratamiento de insuficiencia cardiaca congestiva.
Hirawa et al. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats
WO1992020651A3 (en) N-(heteroaryl)-imidazolyl-alkenoic acids
MX9709976A (es) Terapia de combinacion con espironolactona y antagonista de angiotensina ii para el tratamiento de fallas cardiacas congestivas.
WO1992005161A1 (en) 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
CA2294515A1 (en) Eprosartan monohydrate
AU3635893A (en) Triazolopyrimidin derivatives as antiotensin II receptor antagonists
NZ504898A (en) (e)-3-[1-n-butyl-5-[2-(2-carboxyphenyl)methoxy-4-chlorophenyl]-1h-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-enoic acid monoargininyl salt as an endothelin receptor antagonist

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees